A Phase 2, Double-blinded, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Allogeneic Dermal Fibroblasts (TPX-115) in Patients With Partial-thickness Rotator Cuff Tear
Latest Information Update: 27 Oct 2025
At a glance
- Drugs TPX-115 (Primary)
- Indications Rotator cuff injuries
- Focus Therapeutic Use
- Sponsors Tego Science
Most Recent Events
- 27 Oct 2025 New trial record